Context Heavy consumption of alcohol can lead to heart failure, but the relationship
between moderate alcohol consumption and risk of heart failure is largely
unknown.
Objective To determine whether moderate alcohol consumption predicts heart failure
risk among older persons, independent of the association of moderate alcohol
consumption with lower risk of myocardial infarction (MI).
Design Prospective cohort study conducted from 1982 through 1996, with a maximum
follow-up of 14 years.
Setting and Participants Population-based sample of 2235 noninstitutionalized elderly persons
(mean age, 73.7 years; 41.2% male; 21.3% nonwhite) residing in New Haven,
Conn, who were free of heart failure at baseline. Persons who reported alcohol
consumption of more than 70 oz in the month prior to baseline were excluded.
Main Outcome Measure Time to first fatal or nonfatal heart failure event, according to the
amount of alcohol consumed in the month prior to baseline.
Results Increasing alcohol consumption in the moderate range was associated
with decreasing heart failure rates. For persons consuming no alcohol (50.0%),
1 to 20 oz (40.2%), and 21 to 70 oz (9.8%) in the month prior to baseline,
crude heart failure rates per 1000 years of follow-up were 16.1, 12.2, and
9.2, respectively. After adjustment for age, sex, race, education, angina,
history of MI and diabetes, MI during follow-up, hypertension, pulse pressure,
body mass index, and current smoking, the relative risks of heart failure
for those consuming no alcohol, 1 to 20 oz, and 21 to 70 oz in the month prior
to baseline were 1.00 (referent), 0.79 (95% confidence interval [CI], 0.60-1.02),
and 0.53 (95% CI, 0.32-0.88) (P for trend = .02).
Conclusions Increasing levels of moderate alcohol consumption are associated with
a decreasing risk of heart failure among older persons. This association is
independent of a number of confounding factors and does not appear to be entirely
mediated by a reduction in MI risk.
Heavy alcohol consumption can have toxic effects on the heart that result
in heart failure.1,2 The relationship
between moderate alcohol consumption and risk of heart failure, however, is
largely unknown. One study of patients hospitalized for myocardial infarction
(MI) reported that compared with patients consuming little or no alcohol,
those reporting moderate consumption had a nonsignificantly lower odds of
developing heart failure during hospitalization.3
Investigators have also shown that among persons with existing left ventricular
systolic dysfunction, light to moderate drinking is a favorable prognostic
factor.4 However, prospective community-based
studies of moderate alcohol consumption and heart failure risk among persons
free of heart failure at baseline have not been conducted. One would naturally
expect such studies to show that moderate alcohol consumption is associated
with a lower risk of heart failure, simply because moderate drinking is associated
with a reduced risk of MI5,6 and
MI is a major risk factor for heart failure. Yet, moderate alcohol consumption,
perhaps by lowering blood pressure7,8
or by promoting neurohormonal changes that prevent the clinical onset of heart
failure,9,10 might reduce heart
failure risk via pathways that do not necessarily involve MI.
Demonstration of an association between moderate alcohol consumption
and lower heart failure risk that is independent of the association of alcohol
consumption with lower MI risk would be important, because it would indicate
that moderate alcohol consumption protects against adverse cardiovascular
processes beyond those related to ischemic heart disease. Furthermore, the
establishment of such an association in older persons might be of particular
importance from a public health standpoint, because light to moderate drinking
is engaged in by a notable proportion of older persons (around 20%),11 and heart failure is one of the leading causes of
hospitalization of the elderly.12 In the current
study, we used a community-based sample of elderly persons to prospectively
examine whether moderate alcohol consumption, compared with no alcohol consumption,
was associated with a lower risk of heart failure, independent of any reduction
in MI risk.
Study Design and Population
The current study is based on data from the New Haven, Conn, site of
the Established Populations for the Epidemiologic Study of the Elderly program
(EPESE), funded by the National Institute on Aging.13
The New Haven EPESE is a prospective cohort study of community-based persons
aged 65 years and older. The cohort was assembled in 1982 by obtaining a stratified
probability sample of persons from 3 New Haven housing strata: public housing
for the elderly, private housing for the elderly, and general housing in the
community. Sampling from these strata yielded 2812 persons who agreed to participate
in the study (the response rate was 82%). At baseline, trained interviewers
administered a structured, 75-page questionnaire to all participants to obtain
information on a variety of factors. We excluded 311 persons who were considered
potential heart failure cases at baseline, defined as use of both loop diuretics
and cardiac glycosides or self-reported symptoms of orthopnea based on affirmative
answers to the following 2 questions: "Do you get shortness of breath when
you are lying down flat?" and "Does this shortness of breath improve when
you sit up, or do you use extra pillows at night to prevent it?" We additionally
excluded 219 persons with missing data on alcohol consumption or other study
variables used in multivariable analyses. Because the number of persons reporting
heavy alcohol consumption was small (n = 47), which made it difficult to analyze
heavy consumers as a separate group, and because we were primarily interested
in the effect of moderate alcohol consumption on heart failure risk relative
to little or no consumption, we further excluded the 47 heavy consumers (see
below for description of alcohol consumption levels). After all exclusions,
the sample size for the study was 2235. Participants were followed up from
1982 to 1996 (maximum follow-up time was 14 years).
Ascertainment of Alcohol Consumption
At baseline, interviewers asked participants how many bottles or cans
of beer, glasses of wine, and drinks of liquor they had consumed in the preceding
month. From this information, we calculated the total intake of pure alcohol
(in ounces) for the month to be: 0.48 × the number of bottles or cans
of beer + 0.60 × the number of glasses of wine + 0.675 × the number
of drinks of liquor. This formula was based on a national survey of alcohol
consumption taken around the time of the baseline interview14
and has been used in a prior study of alcohol consumption and coronary heart
disease.15 Participants were categorized into
the following 3 groups based on the total ounces consumed in the prior month:
0, 1 to 20 oz (30-600 mL) (up to approximately 1 or 1.5 drinks per day), and
21 to 70 oz (630-2100 mL) (about 1.5 to 4 drinks per day). The middle category
was chosen because studies have shown that consumption of less than 1 or 1.5
drinks per day can have protective effects against adverse cardiovascular
outcomes.16,17 The 21- to 70-oz
category was chosen because some evidence suggests that consumption of more
than 2 drinks per day may also have protective effects against adverse cardiovascular
outcomes.6 Those persons consuming more than
70 oz in the month before baseline were considered heavy consumers and were
excluded from analyses.
Our analyses controlled for the effects of other study measures thought
to be associated with the risk of heart failure including age, sex, race (white
vs nonwhite), education, angina, self-reported history of physician-diagnosed
MI or diabetes, and hypertension based on measured levels of blood pressure
and antihypertensive medication use (no hypertension: systolic blood pressure
[SBP] <140 mm Hg, diastolic blood pressure [DBP] <90 mm Hg, and no antihypertensive
medications; stage I hypertension: SBP ≥140 to 160 mm Hg or DBP ≥90
to 100 mm Hg in persons not taking antihypertensive medications; stage II
hypertension: SBP ≥160 mm Hg or DBP ≥100 mm Hg or current use of antihypertensive
medications). We also considered baseline pulse pressure in our analyses because
this factor shows a strong, graded association with heart failure risk in
the New Haven EPESE.18 Baseline smoking status
(current vs past or never) and body mass index (BMI; 4 categories: ≤23
kg/m2, 24-27 kg/m2, ≥28 kg/m2, and missing)
were also controlled for. In addition to controlling for baseline history
of MI, we also controlled for the development of MI during follow-up. Ascertainment
of MI during follow-up in the New Haven EPESE has been described previously.19
Ascertainment of Heart Failure
The principal outcome in this study was the occurrence of a heart failure
event (nonfatal or fatal). Although some persons in the New Haven EPESE experienced
multiple heart failure events during follow-up, we only considered the first
event in our analyses. Nonfatal events were identified through surveillance
of 2 New Haven area hospitals where over 90% of the hospital admissions for
the New Haven EPESE cohort occurred. Surveillance of these 2 hospitals was
supplemented by information from the Health Care Financing Administration.
Participants whose primary or first 3 secondary hospital discharge diagnoses
included International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM)
codes 428, 402.01, 402.11, 402.91, 404.01, 404.13, 404.91, or 404.93 were
identified and their records were reviewed after follow-up had been completed.
To be considered a nonfatal heart failure case, hospitalization records needed
to indicate the following: (1) symptoms of heart failure, such as dyspnea
or orthopnea; (2) radiographic (eg, cardiomegaly on x-ray) or physical (eg,
pulmonary rales more than basilar, S3 gallop) evidence of heart
failure; (3) heart failure as 1 of the 3 major precipitating factors for hospitalization;
and (4) occurrence of heart failure symptoms prior to or within 24 hours of
hospitalization. Heart failure has been defined in a similar manner by other
studies.20,21 Identification of
fatal heart failure events was made by examining death certificates, which
were coded by a single nosologist. Death certificates in which the underlying
cause of death was listed as ICD-9-CM code 428, 402.01,
402.11, 402.91, 404.01, 404.13, 404.91, or 404.93 were considered to be fatal
heart failure events. Ascertainment of vital status was nearly complete (>99%).
The first step in the analysis was to examine bivariate associations
between the 3 alcohol consumption groups and the other study measures described
above. These bivariate associations were assessed by χ2 tests
when the other study measures were categorical, and by analysis of variance
when the other study measures were continuous (age, years of education, and
pulse pressure). We then constructed Kaplan-Meier curves and used the log-rank
test to compare each alcohol group's unadjusted cumulative probability of
surviving free of heart failure during follow-up. Next, we analyzed the association
between alcohol consumption and risk of heart failure in multivariable statistical
models that adjusted for the effects of the other study measures. Multivariable
adjustment was accomplished by Cox proportional hazards regression,22 with time to first heart failure event as the outcome
of interest. In the multivariable Cox models, the group reporting no consumption
in the prior month was treated as the referent level and the other 2 alcohol
groups were entered as dummy variables. To determine if a linear trend existed
between levels of alcohol consumption and risk of heart failure, we ran multivariable
Cox models with an ordinal alcohol consumption variable that assigned participants
the median ounces of alcohol consumed by their respective alcohol groups.
The development of MI during follow-up was treated as a time-dependent variable
in the Cox models.
We also conducted several secondary analyses. First, the group reporting
no alcohol consumption at baseline may have included persons who quit drinking
as a result of cardiovascular symptoms or illness. It has been argued that
inclusion of such "sick quitters" could lead to a spurious association between
alcohol consumption and reduced risk of subsequent cardiovascular events.23 Investigators have attempted to rule out the possibility
of this type of spurious association by looking at the relationship between
alcohol and cardiovascular events after (1) excluding events within the early
part of the follow-up period,15,17,24
(2) excluding persons with a history of coronary heart disease at baseline
(rather than simply controlling for it at baseline, which could result in
residual confounding due to variations in severity of the pre-existing coronary
heart disease),24 or (3) excluding persons
who reported that their level of alcohol consumption at baseline was noticeably
lower than it had been in the past.15 To see
if our results were influenced by sick quitters, we examined the relationship
between alcohol consumption and heart failure after making the 3 types of
exclusions noted above. Second, we analyzed whether our results were affected
by controlling for time-dependent covariates that measured diabetes status,
presence of hypertension, and pulse pressure during follow-up (3, 6, and 12
years after baseline). Third, recent evidence suggests that the protective
effect of alcohol against coronary heart disease may depend on the type of
alcoholic beverage consumed, with a higher level of protection being seen
among wine drinkers.16 To see if the risk of
heart failure depended on the type of alcohol consumed, we ran separate analyses
for wine, beer, and liquor.
The New Haven EPESE was a complex survey that involved sampling weights,
stratification, and clustering. These aspects of the survey can have effects
on point estimates and SEs, and these effects have been accounted for in previous
New Haven EPESE studies by using SUDAAN (Research Triangle Institute, Research
Triangle Park, NC) for data analyses.19 However,
we found that for the alcohol variables, results in SAS (SAS Institute, Cary,
NC) and SUDAAN were very similar. Because the results were similar, and because
SUDAAN did not allow us to incorporate time-dependent covariates in Cox proportional
hazards regression models, we used SAS for all statistical analyses.
The average age of the study population was 73.7 years. Approximately
41.2% of participants were male, and 21.3% were nonwhite. Approximately 50.0%
of persons reported no alcohol consumption in the month before baseline, while
40.2% reported consumption of 1 to 20 oz and 9.8% reported consumption of
21 to 70 oz. Table 1 shows bivariate
associations between alcohol consumption and the other study variables. Those
consuming higher levels of alcohol were significantly younger, more likely
to be male, less likely to be nonwhite, and had higher educational levels.
They were also less likely to have a history of diabetes, less likely to have
stage II hypertension at baseline, and more likely to be current smokers.
Those who consumed higher levels of alcohol also appeared to be less likely
to have a low BMI or missing data on BMI. Those who consumed 1 to 20 oz in
the month before baseline were significantly less likely to have a history
of MI compared with those with lower or higher levels of consumption.
During follow-up, a total of 281 persons experienced a first heart failure
event (28 of these events were fatal). Table 2 shows crude heart failure event rates, according to alcohol
consumption level. Those reporting higher levels of alcohol consumption had
lower rates of heart failure. For those consuming no alcohol, 1 to 20 oz of
alcohol, and 21 to 70 oz of alcohol, the event rates per 1000 person-years
of follow-up were 16.1, 12.2, and 9.2, respectively. Although not included
in our analyses, the group reporting more than 70 oz of alcohol consumption
had a comparatively low heart failure rate (7.0 events per 1000 person-years
of follow-up). Unadjusted survival curves showing each group's cumulative
probability of surviving free of heart failure are presented in Figure 1. A log-rank test indicated that the difference between
these curves was significant (P = .01).
To examine the association between alcohol consumption and heart failure
after adjusting for other factors, we ran multivariable Cox proportional hazards
models (Table 3). After adjustment
for age and sex (model 1), the relative risks (RRs) of heart failure were
1.00 (referent), 0.71 (95% confidence interval [CI], 0.56-0.92), and 0.47
(95% CI, 0.29-0.76) (P for trend = .01) for those
consuming no alcohol in the past month, 1 to 20 oz of alcohol, and 21 to 70
oz of alcohol, respectively. On additional adjustment for race, education,
angina, history of MI and diabetes, MI during follow-up as a time-dependent
covariate, hypertension, pulse pressure, BMI, and current smoking status (model
2), the RRs for increasing levels of alcohol consumption were 1.00 (referent),
0.79 (95% CI, 0.60-1.02), and 0.53 (95% CI, 0.32-0.88) (P for trend = .02).
We then conducted several sets of secondary analyses. First, we attempted
to rule out possible bias due to the inclusion of sick quitters in the group
who reported no consumption of alcohol at baseline. We therefore ran fully
adjusted Cox models that excluded the first 2 years of follow-up, excluded
persons with a history of MI at baseline, or excluded persons who reported
having curtailed their alcohol consumption prior to baseline. After making
these exclusions, we found that increasing levels of alcohol consumption remained
associated with a decreasing risk of heart failure. For example, when excluding
the first 2 years of follow-up, the risk of heart failure was 1.00 (referent),
0.82 (95% CI, 0.62-1.09), and 0.54 (95% CI, 0.32-0.92) (P for trend = .03) for those consuming no alcohol, 1 to 20 oz, and
21 to 70 oz of alcohol, respectively. After excluding those with a history
of MI at baseline, results were 1.00 (referent), 0.76 (95% CI, 0.57-1.00),
and 0.47 (95% CI, 0.26-0.85) (P for trend = .02).
And after excluding those who reported heavier alcohol consumption at some
time in the past, the results for the 3 levels of alcohol consumption were
1.00 (referent), 0.76 (95% CI, 0.55-1.05), and 0.31 (95% CI, 0.15-0.67) (P for trend = .002).
Second, we attempted to determine if incident diabetes during follow-up,
or hypertension and pulse pressure during follow-up, could explain our results.
To make this determination, we ran a fully adjusted Cox model with time-dependent
covariates for diabetes, hypertension, and pulse pressure. Results of this
model were similar to our main analyses; RRs were 1.00 (referent), 0.79 (95%
CI, 0.61-1.03), and 0.55 (95% CI, 0.33-0.90) (P for
trend = .03) for nondrinkers, those consuming 1 to 20 oz of alcohol, and those
consuming 21 to 70 oz of alcohol, respectively.
Third, we analyzed whether the association between alcohol consumption
and risk of heart failure differed according to the type of alcoholic beverage
consumed. Because of the small number of persons drinking more than 20 oz
of any 1 type of beverage in the month before baseline, consumption levels
for each type of beverage were simply categorized as "none" vs "any." The
results of the beverage-specific analyses are presented in Table 4. Consumers of each type of beverage showed similar reductions
in heart failure risk compared with nonconsumers after adjustment for other
factors. None of the specific beverage types showed a significant association
with heart failure after controlling for total alcohol consumption.
Fourth, we sought to determine whether there were significant interactions
between alcohol consumption and other major study variables. Given the relatively
small number of events in the group consuming 21 to 70 oz of alcohol in the
month before baseline, the power to detect interactions in this group was
somewhat limited. Thus, we created a dichotomous "none" vs "any" alcohol consumption
variable and assessed interactions between this dichotomous variable and other
selected study variables (sex, race, diabetes history, and hypertension levels).
In fully adjusted models, however, we failed to find that any of these interactions
were significant.
Finally, we also examined the relationship between alcohol consumption
and total mortality (Table 5).
For those consuming 0, 1 to 20, and 21 to 70 oz of alcohol, the RRs of total
mortality were 1.00 (referent), 0.81 (95% CI, 0.72-0.91), and 0.75 (95% CI,
0.62-0.90) (P for trend = .01) after adjustment for
all of the other study variables. Furthermore, we noticed that controlling
for heart failure during follow-up helped explain a notable amount of the
relationship between moderate alcohol intake and reduced total mortality risk
(data not shown). Moderate alcohol consumption was also associated with a
reduced risk of hospitalization for any cause, but the reduction was not significant
and was not nearly as substantial as the reduction in risk that was seen for
heart failure (data not shown).
The main finding of this study was that compared with no alcohol consumption,
increasing levels of alcohol consumption in the low to moderate range were
associated with a lower risk of heart failure among community-based older
persons. This association was observed after controlling for a number of factors
including age, sex, race, education, angina, history of MI and diabetes, MI
during follow-up, hypertension, pulse pressure, BMI, and smoking. A prior
study had shown that moderate alcohol consumption was associated with a lower
odds of heart failure among persons hospitalized for MI, although the association
was not significant.3 The current study demonstrates
for the first time that moderate alcohol consumption is significantly associated
with a lower risk of heart failure in a community-based population. Our study
also showed that different types of alcoholic beverages (beer, wine, liquor)
were associated with similar reductions in heart failure risk, suggesting
that it is pure alcohol, and not the type of beverage, that is associated
with lower heart failure risk. Overall, moderate drinking did not appear to
be a harmful factor in this study but was, instead, arguably beneficial in
that it was associated with a reduced risk of total mortality.
What could explain our finding that moderate alcohol consumption is
associated with a lower risk of heart failure? First, our results may have
been due to confounding from basic demographic factors such as age, sex, or
socioeconomic status. As noted above, however, our finding was observed after
adjustment for age and sex. It was also observed after adjustment for race
and education levels, both of which can be regarded as rough indicators of
socioeconomic status. Thus, confounding from demographic factors does not
appear to be a likely explanation for our results.
Second, the group reporting no consumption in the month before baseline
may have included persons who quit drinking as a result of symptoms associated
with cardiovascular disease. This could lead to a spurious association between
alcohol consumption and lower risk of cardiovascular events, including heart
failure. Our main analyses minimized the possibility of this spurious association
by excluding persons with heart failure at baseline, based on symptoms and
medication use, and by controlling for history of MI at baseline. Furthermore,
our finding persisted in secondary analyses that excluded persons with a history
of MI at baseline, excluded heart failure events within the first 2 years
of follow-up, and excluded those who reported having curtailed their consumption
of alcohol. These secondary analyses helped to further rule out the possibility
that our finding reflected a scenario in which illness caused people to quit
drinking at baseline.
Third, alcohol consumption may have had physiological effects that reduced
the risk of MI, thereby resulting in lower heart failure risk. Such a pathway
seems reasonable since, on one hand, alcohol consumption may reduce the risk
of MI by increasing high-density lipoprotein cholesterol levels,25
decreasing platelet aggregation,26 and increasing
fibrinolytic activity27 and, on the other hand,
MI is a common antecedent of heart failure. Nevertheless, our study found
that alcohol consumption was associated with lower heart failure risk, even
after controlling for baseline history of MI and MI during follow-up. This
suggests that a reduction in MI risk may not substantially explain the association
we observed. However, during follow-up, we only controlled for MI events that
resulted in hospitalizations. We did not control for other ischemic events
that did not result in hospitalizations, but which could have progressed toward
heart failure, such as silent/unrecognized MI and chronic or unstable angina.
Thus, it is possible that the association between moderate alcohol consumption
and lower heart failure risk is mediated by a reduction in the risk of these
other ischemic events.
Fourth, diabetes and hypertension are strong risk factors for heart
failure. Recent evidence suggests that modest alcohol consumption may reduce
the risk of diabetes.28 There is also evidence
that modest alcohol consumption is associated with lower blood pressure levels
in rats29-31 and
humans.7,8,31,32
Even among people with heart failure, modest alcohol consumption lowers blood
pressure in the short term.33 Yet, we controlled
for hypertension, pulse pressure, and diabetes history at baseline and during
follow-up and still found an inverse relationship between moderate alcohol
consumption and heart failure. As such, alcohol-induced effects on blood pressure
parameters and diabetes may not substantially account for our results.
Fifth, sporadic reports suggest that alcohol may have effects on several
neurohormones that are thought to influence the progression of heart failure.
Norepinephrine and arginine vasopressin are neurohormones that may foster
the progression of heart failure.34,35
Investigators have noted that low-dose alcohol consumption may blunt the effects
of norepinephrine in rats36 and may decrease
plasma levels of arginine vasopressin in humans9
over the short term. It has also been reported that modest alcohol consumption
may lead to short-term increases in plasma levels of atrial natriuretic peptide,9,10 a neurohormone that might act against
the progression of heart failure.37 The neurohormonal
effects of moderate alcohol consumption that are noted above would be consistent
with a protective effect of moderate alcohol consumption against heart failure.
However, the effects of modest alcohol consumption on neurohormonal factors
are not well-established, and any attempt to use such factors to explain the
association of modest alcohol consumption with reduced heart failure risk
is speculative.
Sixth, our study findings may have been affected by misclassification
of alcohol consumption and/or heart failure events. Given the prospective
design of our study, however, any misclassification of alcohol consumption
would likely have been nondifferential. Similarly, it seems likely that misclassification
of heart failure deaths would have been nondifferential, as these deaths were
classified without knowledge of a person's self-reported alcohol intake. Misclassification
of heart failure hospitalizations was also—in all likelihood—nondifferential,
because there is no obvious reason why misclassification of these hospitalizations
would depend on moderate drinking status. Thus, although there may have been
some misclassification of alcohol consumption and heart failure in this study,
this misclassification was probably nondifferential in nature. Nondifferential
misclassification biases associations toward the null and could not, therefore,
explain away the protective association we found between moderate drinking
and lower heart failure risk. Instead, such misclassification suggests that
we may have underestimated the protective effect of moderate drinking against
heart failure.
Although our results suggest that moderate alcohol consumption may reduce
the risk of heart failure, it is important to point out that our investigation
was not a true experiment but was, instead, an observational study. As such,
our results may have been due to some confounding factor that we failed to
control for. Moderate drinking may simply be correlated with a healthy diet
or other healthy lifestyle practices. We had no information on diet and cannot
rule out that it or other unmeasured factors confounded our results. Therefore,
our results should be interpreted with caution.
In conclusion, this study provides evidence that increasing levels of
moderate alcohol consumption are associated with a decreasing risk of heart
failure among community-based older persons. This association is independent
of a number of potential confounding factors and does not appear to be mediated
by a reduction in the risk of MI. The community-based nature of our study
population suggests that the results of this study may have wide applicability.
Heavy consumption of alcohol can lead to negative cardiovascular outcomes
such as higher blood pressure,8 cardiomyopathy,2 and sudden cardiac death.38
Thus, individuals should continue to be cautioned against drinking excessive
amounts of alcohol. Nevertheless, this study adds to the growing evidence
that moderate consumption of alcohol may be beneficial to the cardiovascular
system.
1.Urbano-Marquez A, Estruch R, Navarro-Lopez F.
et al. The effects of alcoholism on skeletal and cardiac muscle.
N Engl J Med.1989;320:409-415.Google Scholar 2.Rubin E, Urbano-Marquez A. Alcoholic cardiomyopathy.
Alcohol Clin Exp Res.1994;18:111-114.Google Scholar 3.Mukamal KJ, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Lack of effect of recent alcohol consumption on the course of acute
myocardial infarction.
Am Heart J.1999;138:926-933.Google Scholar 4.Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with
left ventricular systolic dysfunction.
J Am Coll Cardiol.2000;35:1753-1759.Google Scholar 5.Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of
myocardial infarction.
Epidemiol Rev.1993;15:328-351.Google Scholar 6.Camargo Jr CA, Stampfer MJ, Glynn RJ.
et al. Moderate alcohol consumption and risk for angina pectoris or myocardial
infarction in U.S. male physicians.
Ann Intern Med.1997;126:372-375.Google Scholar 7.Jackson R, Stewart A, Beaglehole R, Scragg R. Alcohol consumption and blood pressure.
Am J Epidemiol.1985;122:1037-1044.Google Scholar 8.Klatsky AL, Friedman GD, Siegelaub AB, Gerard MJ. Alcohol consumption and blood pressure: Kaiser-Permanente Multiphasic
Health Examination data.
N Engl J Med.1977;296:1194-1200.Google Scholar 9.Gianoulakis C, Guillaume P, Thavundayil J, Gutkowska J. Increased plasma atrial natriuretic peptide after ingestion of low
doses of ethanol in humans.
Alcohol Clin Exp Res.1997;21:162-170.Google Scholar 10.Colantonio D, Casale R, Desiati P.
et al. A possible role of atrial natriuretic peptide in ethanol-induced acute
diuresis.
Life Sci.1991;48:635-642.Google Scholar 11. Drinking in the United States: Main Findings From the 1992 National
Longitudinal Alcohol Epidemiologic Survey (NLAES). Bethesda, Md: National Institutes of Health; November 1998.
12.Kozak LJ, Lawrence L. National Hospital Discharge Survey: annual summary, 1997.
Vital Health Stat 13.1999;(144):i-iv, 1-46.Google Scholar 13.Cornoni-Huntley J, Ostfeld AM, Taylor JO.
et al. Established populations for epidemiologic studies of the elderly: study
design and methodology.
Aging (Milano).1993;5:27-37.Google Scholar 14.Malin H, Wilson RW, Williams GD. 1983 NHIS Alcohol/Health Practices Supplement: Preliminary
Findings: Proceedings of the 1985 Public Health Conference
on Records and Statistics. Hyattsville, Md: US Public Health Service; 1986:490-495.
15.Valmadrid CT, Klein R, Moss SE, Klein BE, Cruickshanks KJ. Alcohol intake and the risk of coronary heart disease mortality in
persons with older-onset diabetes mellitus.
JAMA.1999;282:239-246.Google Scholar 16.Gronbaek M, Becker U, Johansen D.
et al. Type of alcohol consumed and mortality from all causes, coronary heart
disease, and cancer.
Ann Intern Med.2000;133:411-419.Google Scholar 17.Solomon CG, Hu FB, Stampfer MJ.
et al. Moderate alcohol consumption and risk of coronary heart disease among
women with type 2 diabetes mellitus.
Circulation.2000;102:494-499.Google Scholar 18.Vaccarino V, Holford TR, Krumholz HM. Pulse pressure and risk for myocardial infarction and heart failure
in the elderly.
J Am Coll Cardiol.2000;36:130-138.Google Scholar 19.Mendes de Leon CF, Krumholz HM, Seeman TS.
et al. Depression and risk of coronary heart disease in elderly men and women:
New Haven EPESE, 1982-1991.
Arch Intern Med.1998;158:2341-2348.Google Scholar 20.Harlan WR, Oberman A, Grimm R, Rosati RA. Chronic congestive heart failure in coronary artery disease: clinical
criteria.
Ann Intern Med.1977;86:133-138.Google Scholar 21.Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United
States.
J Am Coll Cardiol.1992;20:301-306.Google Scholar 22.Cox DR. Regression models and life tables.
J R Stat Soc B.1972;34:187-220.Google Scholar 23.Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U -shaped curve.
Lancet.1988;2:1267-1273.Google Scholar 24.Albert CM, Manson JE, Cook NR.
et al. Moderate alcohol consumption and the risk of sudden cardiac death among
US male physicians.
Circulation.1999;100:944-950.Google Scholar 25.Gaziano JM, Buring JE, Breslow JL.
et al. Moderate alcohol intake, increased levels of high-density lipoprotein
and its subfractions, and decreased risk of myocardial infarction.
N Engl J Med.1993;329:1829-1834.Google Scholar 26.Rubin R. Effect of ethanol on platelet function.
Alcohol Clin Exp Res.1999;23:1114-1118.Google Scholar 27.Ridker PM, Vaughan DE, Stampfer MJ.
et al. Association of moderate alcohol consumption and plasma concentration
of endogenous tissue-type plasminogen activator.
JAMA.1994;272:929-933.Google Scholar 28.Ajani UA, Hennekens CH, Spelsberg A, Manson JE. Alcohol consumption and risk of type 2 diabetes mellitus among US male
physicians.
Arch Intern Med.2000;160:1025-1030.Google Scholar 29.Guillaume P, Jankowski M, Gianoulakis C, Gutkowska J. Effect of chronic ethanol consumption on the atrial natriuretic system
of spontaneously hypertensive rats.
Alcohol Clin Exp Res.1996;20:1653-1661.Google Scholar 30.Howe PR, Rogers PF, Smith RM. Antihypertensive effect of alcohol in spontaneously hypertensive rats.
Hypertension.1989;13:607-611.Google Scholar 31.Vasdev S, Ford CA, Longerich L.
et al. Antihypertensive effect of low ethanol intake in spontaneously hypertensive
rats.
Mol Cell Biochem.1999;200:85-92.Google Scholar 32.Gillman MW, Cook NR, Evans DA.
et al. Relationship of alcohol intake with blood pressure in young adults.
Hypertension.1995;25:1106-1110.Google Scholar 33.Greenberg BH, Schutz R, Grunkemeier GL, Griswold H. Acute effects of alcohol in patients with congestive heart failure.
Ann Intern Med.1982;97:171-175.Google Scholar 34.Mann DL. Mechanisms and models in heart failure: a combinatorial approach.
Circulation.1999;100:999-1008.Google Scholar 35.Goldsmith SR, Francis GS, Cowley Jr AW, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive
heart failure.
J Am Coll Cardiol.1983;1:1385-1390.Google Scholar 36.Criscione L, Powell JR, Burdet R.
et al. Alcohol suppresses endothelium-dependent relaxation in rat mesenteric
vascular beds.
Hypertension.1989;13:964-967.Google Scholar 37.Brandt RR, Wright RS, Redfield MM, Burnett Jr JC. Atrial natriuretic peptide in heart failure.
J Am Coll Cardiol.1993;22:86A-92A.Google Scholar 38.Wannamethee G, Shaper AG. Alcohol and sudden cardiac death.
Br Heart J.1992;68:443-448.Google Scholar